Literature DB >> 6874629

The fractional inhibitory concentration (FIC) index as a measure of synergy.

M J Hall, R F Middleton, D Westmacott.   

Abstract

The value of the FIC index as a predictor of synergy has been investigated using the antibacterial agents alafosfalin and cephalexin combined together with themselves in fully blind experiments. Under the conditions used, even weak interaction (FIC index 0.5-0.99) proved to be statistically highly significant. The use of such fully controlled blind studies would greatly enhance the credibility of many of the claims of synergy published in the literature. The representation of results as average isobolograms is only of value with combinations which show moderate to strong interaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874629     DOI: 10.1093/jac/11.5.427

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  90 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

Authors:  Christine L Clouser; Colleen M Holtz; Mary Mullett; Daune L Crankshaw; Jacquie E Briggs; M Gerard O'Sullivan; Steven E Patterson; Louis M Mansky
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

3.  Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.

Authors:  Mathias Schmelcher; Anne M Powell; Stephen C Becker; Mary J Camp; David M Donovan
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

4.  In vitro synergy studies with Clostridium difficile.

Authors:  A E Bacon; S McGrath; R Fekety; W J Holloway
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.

Authors:  Quinton L Fivelman; Ipemida S Adagu; David C Warhurst
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Identification of Peptidoglycan Hydrolase Constructs with Synergistic Staphylolytic Activity in Cow's Milk.

Authors:  Carolin T Verbree; Steven M Dätwyler; Susanne Meile; Fritz Eichenseher; David M Donovan; Martin J Loessner; Mathias Schmelcher
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

7.  Potentiation of the activity of β-lactam antibiotics by farnesol and its derivatives.

Authors:  Choon Kim; Dusan Hesek; Mijoon Lee; Shahriar Mobashery
Journal:  Bioorg Med Chem Lett       Date:  2018-01-31       Impact factor: 2.823

8.  Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus.

Authors:  Joseph Meletiadis; Spyros Pournaras; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

9.  AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria.

Authors:  Cameron T McDaniel; Warunya Panmanee; Geoffrey L Winsor; Erin Gill; Claire Bertelli; Michael J Schurr; Prateek Dongare; Andrew T Paul; Seung-Hyun B Ko; Gee W Lau; Nupur Dasgupta; Amy L Bogue; William E Miller; Joel E Mortensen; David B Haslam; Phillip Dexheimer; Daniel A Muruve; Bruce J Aronow; Malcolm D E Forbes; Marek Danilczuk; Fiona S L Brinkman; Robert E W Hancock; Thomas J Meyer; Daniel J Hassett
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

10.  Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.

Authors:  P Angehrn; M J Hall; W J Lloyd; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.